echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > JGH: Lower endoscopy rates associated with higher mortality in patients with end-stage renal disease with gastrointestinal bleeding

    JGH: Lower endoscopy rates associated with higher mortality in patients with end-stage renal disease with gastrointestinal bleeding

    • Last Update: 2022-01-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recent studies have shown that patients with end-stage renal disease (ESRD) undergoing hemodialysis have a higher risk of gastrointestinal bleeding (GIB) compared with patients without renal disease (NRD)


    Recent studies have shown that patients with end-stage renal disease (ESRD) undergoing hemodialysis have a higher risk of gastrointestinal bleeding (GIB) compared with patients without renal disease (NRD)


     

    Patients admitted for GIB (upper and lower) from 2005 to 2013 were extracted from the NIS database using the ICD-9 disease diagnosis


    diagnosis

     

    A total of 218,032 patients were included in the study


     

    This study found that ESRD patients with GIB had significantly higher mortality, higher healthcare utilization, but lower rates of endoscopic assessment


    This study found that ESRD patients with GIB had significantly higher mortality, higher healthcare utilization, but lower rates of endoscopic assessment


    Rajat Garg.


    Lower rates of endoscopy and higher mortality in end-stage renal disease patients with gastrointestinal bleeding: A propensity matched national study.


    Leave a comment here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.